about
Speech-induced striatal dopamine release is left lateralized and coupled to functional striatal circuits in healthy humans: a combined PET, fMRI and DTI studySimultaneous PET/MRI Imaging During Mouse Cerebral Hypoxia-ischemia.A computerized infusion pump for control of tissue tracer concentration during positron emission tomography in vivo pharmacokinetic/pharmacodynamic measurements.Changes in striatal dopamine release associated with human motor-skill acquisitionDiscovery and labeling of high-affinity 3,4-diarylpyrazolines as candidate radioligands for in vivo imaging of cannabinoid subtype-1 (CB1) receptors.Assessment of receptor occupancy-over-time of two dopamine transporter inhibitors by [(11)C]CIT and target controlled infusionIntravenous ethanol increases dopamine release in the ventral striatum in humans: PET study using bolus-plus-infusion administration of [(11)C]raclopride.Assessing the sensitivity of [¹¹C]p943, a novel 5-HT1B radioligand, to endogenous serotonin release.Quantification of metabotropic glutamate subtype 5 receptors in the brain by an equilibrium method using 18F-SP203Effect of secondhand smoke on occupancy of nicotinic acetylcholine receptors in brain.Relative equilibrium plot improves graphical analysis and allows bias correction of standardized uptake value ratio in quantitative 11C-PiB PET studies.Feedback-controlled bolus plus infusion (FC-B/I) method for quantitative drug assessment in living brain with PET.Kinetic analysis of the metabotropic glutamate subtype 5 tracer [(18)F]FPEB in bolus and bolus-plus-constant-infusion studies in humansTest-retest reproducibility of [11C]-(+)-propyl-hexahydro-naphtho-oxazin positron emission tomography using the bolus plus constant infusion paradigm.On the rate and extent of drug delivery to the brain.Striatal dopaminergic dysfunction at rest and during task performance in writer's cramp.Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors.Brain nicotinic acetylcholine receptor occupancy: effect of smoking a denicotinized cigarette.The dopaminergic basis of human behaviors: A review of molecular imaging studies.Integrating PET with behavioral neuroscience using RatCAP tomography.Determination of the Input Function at the Entry of the Tissue of Interest and Its Impact on PET Kinetic Modeling Parameters.Imaging of cerebral α4β2* nicotinic acetylcholine receptors with (-)-[(18)F]Flubatine PET: Implementation of bolus plus constant infusion and sensitivity to acetylcholine in human brain.Consideration of optimal time window for Pittsburgh compound B PET summed uptake measurementsDevelopment of an H(2)(15)O steady-state method combining a bolus and slow increasing injection with a multiprogramming syringe pumpIn vivo measures of dopaminergic radioligands in the rat brain: equilibrium infusion studies.Nicotine-induced dopamine release in primates measured with [11C]raclopride PET.Quantitative PET Imaging in Drug Development: Estimation of Target Occupancy.Simultaneous assessment of rodent behavior and neurochemistry using a miniature positron emission tomograph.Multimodality imaging of blood-brain barrier impairment during epileptogenesis.Quantitative study of F-(+)DTBZ image: comparison of PET template-based and MRI based image analysis
P2860
Q28707279-C6175DA3-556A-4A9D-BD07-50BCB8179A10Q31001475-AC6CD4F9-DE51-4981-8C52-7C532B418417Q33338968-16C55801-5045-4F46-96C9-FB12A624F6DCQ34166461-70C99A79-3D4C-4C9D-94BE-F2CE842CE5B6Q34278963-A635E289-8A1F-48D2-B854-C2A77BF96D0BQ34806210-47E92160-089A-427C-B05D-3BE36E72A373Q35143469-4AB3B44A-2863-47DE-93F4-06E007012781Q35146221-B4FB6C73-C0CD-46FE-AF1B-5727F6ADD127Q35663423-ED94306D-470F-4C8D-A32D-C10A8FAD3E50Q36050801-EF9FECAD-3720-4AD6-9BFD-A41C982EA76CQ36253478-AE79E185-6903-4003-B588-74D527C1C0DEQ36684186-F4CA9482-6C3F-4E7B-A585-594B8C2440AEQ36745084-EC577903-9CCE-459D-A5B5-DBDCDE84282EQ36976960-4D66A4F5-BFD2-49E6-AD77-FC53030F6335Q37023904-1F3BC6B5-1535-45F1-BC18-053C0CFBB130Q37383467-BF03E104-EDEA-4154-9E78-0FB717C57052Q37412735-A7DDC696-8AC7-4094-A326-2809052B5590Q37412757-26C4A916-F3A4-4BDA-80D8-7F15F1DAA11EQ37500893-92B71B7E-2AB7-4E25-BA66-C20A62583194Q37958076-92074BA2-6256-4F25-A66E-081B7F99EC03Q38591292-622D0C7A-D43F-4B27-9673-CE0BBDF3BC5AQ38840893-0A6FE4F3-7248-46FE-80CD-96AF7A58A01DQ41551180-FAD38AFF-3A09-4404-B80A-4C32203D3075Q42092754-983EB275-26D1-4322-B9A0-838902A2BD9AQ43856181-F8ADB340-002A-412B-83D2-E26106B78E92Q44686779-A4FDCD0C-1B4F-48FF-BE47-68FC8B8445DEQ46243170-3F3358C4-93C2-43A4-A4D6-2D29A7FFB068Q48279606-2F2F06CB-8516-43FC-9C31-09AE49433E25Q48615110-F9F1BC1C-F433-4194-96F8-D9B8A3433A5AQ58099045-10508D82-4465-4283-9949-CF1E7ACE5E61
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
PET physiological measurements using constant infusion.
@ast
PET physiological measurements using constant infusion.
@en
PET physiological measurements using constant infusion.
@nl
type
label
PET physiological measurements using constant infusion.
@ast
PET physiological measurements using constant infusion.
@en
PET physiological measurements using constant infusion.
@nl
prefLabel
PET physiological measurements using constant infusion.
@ast
PET physiological measurements using constant infusion.
@en
PET physiological measurements using constant infusion.
@nl
P1476
PET physiological measurements using constant infusion.
@en
P2093
P304
P356
10.1016/S0969-8051(00)00138-4
P577
2000-10-01T00:00:00Z